Medicines Development For Global Healthmdghis An Independentnot For Profit Biopharmaceutical Company Founded In 2005 By Mark Sullivanthe Organization Is Dedicated To Developing Affordable Medicines And Vaccines For Disadvantaged Communities Worldwidefocusing On Health Inequities And Neglected Diseases That Primarily Affect Lowand Middle Income Countries Mdgh Employs A Resource Efficient Development Model That Integrates Expertise At Every Stage Of The Processthe Company Has Achieved Significant Milestonesincluding The Fda Approval Of Moxidectin In 2018The First New Treatment For River Blindness In Two Decadesmdgh Is Also Developing Dovramilastan Investigational Treatment With Potential Applications In Tuberculosis And Leprosy Type 2 Reactiontheir Services Include Regulatory Sciencemedicine Development For Neglected Diseasesand Implementation Support For New Medicine Programs In Underserved Regions
No conferences found for this company.
| Company Name | Medicines Development Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
